Bu sayfada
DNA Sınıf A Ginkgo Bioworks Holdings, Inc. Class A Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$12,35
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$5,3752 haftanın en düşüğü
$17,5852 haftanın en yükseği
Piyasa Değeri (MRQ)
$787M
P/E
-2.3
Hisse Başına Kâr
$-5.64
Gelir
$170M
rozetleriniz
52 Haftlık Aralık
$5–$18
Analist Derecelendirmesi
SELL
Fiyat Hedefi
$7
P/E
-2.3
ROE
-55.8%
Net Kâr Marjı
-260.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
DNA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$12.35
Piyasa Değeri (MRQ)
$787M
P/E
-2.3
Hisse Başına Kâr
$-5.64
Gelir
$170M
ROE
-55.8%
52 Haftlık Aralık
$5–$18
DNA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 20 Ağustos 2024 | 1-for-40 | Ters |
Ginkgo Bioworks Holdings, Inc. Class A Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriLife Sciences Tools & Services
çalışanlar485
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$170M2019-12-31 → 2025-12-31
Hisse Başına Kâr$-5.642019-12-31 → 2025-12-31
Serbest Nakit Akışı$-179M2022-12-31 → 2025-12-31
Net kar marjı-260.0%2022-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | DNA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -2.35Y ort. ≈-49.3 | ≈-49.3 | · | · | |
| F/S (TTM) | 7.05Y ort. ≈202.7 | ≈202.7 | · | · | |
| F/D (MRQ) | 1.95Y ort. ≈49.7 | ≈49.7 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -4.55Y ort. ≈-206.6 | ≈-206.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -4.65Y ort. ≈-242.4 | ≈-242.4 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 2.15Y ort. ≈115.0 | ≈115.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | DNA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -259.9%5Y ort. ≈-309.5% | ≈-309.5% | · | · | |
| EBITDA Margin (FAVÖK Marjı) | -185.3%5Y ort. ≈-309.5% | ≈-309.5% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -264.1%5Y ort. ≈-306.2% | ≈-306.2% | · | · | |
| Net Kâr Marjı (TTM) | -260.0%5Y ort. ≈-305.1% | ≈-305.1% | · | · | |
| ROA | -25.1%5Y ort. ≈-48.7% | ≈-48.7% | · | · | |
| ROE | -55.8%5Y ort. ≈-84.1% | ≈-84.1% | · | · | |
| ROIC | -61.8%5Y ort. ≈-86.3% | ≈-86.3% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | DNA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 4.65Y ort. ≈6.3 | ≈6.3 | · | · | |
| Quick Ratio (Cari Oran) | 4.75Y ort. ≈6.0 | ≈6.0 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | DNA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -25.1%5Y ort. ≈55.9% | ≈55.9% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -29.1%5Y ort. ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 17.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | DNA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.15Y ort. ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 7.45Y ort. ≈7.2 | ≈7.2 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$350.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
2.6%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $-0.75 | $-0.92 | 18.4% | |
| 31 Mart 2026 | $-1.39 | $-1.09 | -27.4% | |
| 31 Aralık 2025 | $-1.41 | $-1.47 | 4.1% | |
| 30 Eylül 2025 | $-1.45 | $-1.25 | -15.8% | |
| 30 Haziran 2025 | $-1.10 | $-1.58 | 30.5% | |
| 31 Mart 2025 | $-1.68 | $-1.79 | 6.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.74 | $13.17 | $0.55 | $0.92 | · | · | · | |
| Revenue / Share | $3.07 | $4.38 | $0.13 | $0.28 | · | · | · | |
| Cash Flow / Share | $-3.08 | $-6.16 | $-0.15 | $-0.15 | · | · | · | |
| Cash / Share | $2.87 | $10.33 | $0.47 | $0.70 | · | · | · | |
| EPS (TTM) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,240,559 | 51,370,029 | 50,111,460 | · | 48,770,000 | 1,933,437,000 | 1,914,963,000 | · | 1,630,911,000 | |
| Shares (Diluted) | · | · | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,246,129 | 51,375,599 | 50,133,366 | · | 48,770,000 | 1,933,437,000 | 1,916,637,000 | · | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.60 | $7.19 | · | $9.85 | $11.06 | $11.84 | · | $15.03 | $0.40 | $0.49 | · | $0.64 | $0.77 | $0.83 | · | $0.87 | |
| Revenue / Share | · | · | · | $0.70 | $0.90 | $0.89 | · | $1.70 | $0.03 | $0.02 | · | $0.03 | $0.04 | $42.11 | · | $0.04 | |
| Cash Flow / Share | · | · | · | · | · | $-0.95 | · | · | · | $-0.04 | · | · | · | $-47.26 | · | · | |
| Cash / Share | $1.33 | $2.33 | · | $1.95 | $3.67 | $5.71 | · | $11.61 | $0.35 | $0.41 | · | $0.53 | $0.57 | $0.62 | · | $0.79 | |
| EPS (TTM) | $-5.64 | $-5.64 | · | $-6.14 | $-5.77 | $-8.90 | · | $-20.59 | $-25.72 | $-21.58 | · | $-55.42 | $-49.62 | $-49.94 | · | $-2.40 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $131M | · | $160M | $210M | $227M | · | $218M | $184M | $209M | · | $315M | $326M | $390M | · | $528M | |
| Net Income TTM | $-291M | $-304M | · | $-340M | $-315M | $-472M | · | $-651M | $-898M | $-854M | · | $-857M | $-1.22B | $-1.72B | · | $-3.53B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.8 | -1.1 | · | -2.4 | -1.9 | -0.6 | · | -0.4 | -0.5 | -2.2 | · | -1.3 | -1.5 | -1.1 | · | -52.0 | |
| P/S | 5.6 | 2.9 | · | 5.2 | 3.0 | 1.4 | · | 2.0 | 150.7 | 452.1 | · | 453.4 | 446.2 | 263.8 | · | 389.7 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| Earnings Yield | -56.9% | -92.0% | · | -42.1% | -51.3% | -156.1% | · | -252.6% | -192.5% | -46.5% | · | -76.5% | -66.7% | -93.9% | · | -1.9% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $170M | $227M | $251M | $478M | $314M |
| Faaliyet Kâr Marjı % | -185.3% | -246.5% | -343.8% | -462.4% | · |
| Net Gelir | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| Seyreltilmiş Hisse Başı Kâr | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 4.9 | 5.6 | 6.1 | 8.4 | · |
| Cari Oran | 4.7 | 5.4 | 5.9 | 8.1 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-179M | $-382M | $-336M | $-304M | · |
Kurumsal Sahipler (13F) 201 dosya · $379.7M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
201
Tutulan Değer
$379.7M
Yeni pozisyonlar
31
Çıkan pozisyonlar
17
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 31 (-1 önceki Ç'ye göre) | 17 (-12 önceki Ç'ye göre) | 71 (+18 önceki Ç'ye göre) | 37 (-5 önceki Ç'ye göre) | +4.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $42.443.568 | 4.282.903 | 11,18% | Hisse senetleri |
| VIKING GLOBAL INVESTORS LP | $35.449.338 | 3.577.128 | 9,33% | Hisse senetleri |
| Erste Asset Management GmbH | $25.902.147 | 2.536.939 | 6,82% | Hisse senetleri |
| VANGUARD GROUP INC | $24.106.911 | 2.900.952 | 6,35% | Hisse senetleri |
| BAILLIE GIFFORD & CO | $23.701.242 | 2.391.649 | 6,24% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.685.074 | 2.087.293 | 5,45% | Hisse senetleri |
| Anchorage Capital Group, L.L.C. | $17.306.457 | 1.746.363 | 4,56% | Hisse senetleri |
| Legal & General Group Plc | $16.543.944 | 1.669.419 | 4,36% | Hisse senetleri |
| STATE STREET CORP | $14.591.187 | 1.472.370 | 3,84% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $12.112.753 | 1.222.016 | 3,19% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.293.628 | 937.803 | 2,45% | Hisse senetleri |
| Allianz Asset Management GmbH | $7.787.258 | 785.798 | 2,05% | Hisse senetleri |
| UBS Group AG | $6.854.341 | 691.659 | 1,80% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $6.329.279 | 638.676 | 1,67% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $6.160.304 | 621.625 | 1,62% | Hisse senetleri |
| SB INVESTMENT ADVISERS (UK) LTD | $6.052.324 | 610.729 | 1,59% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $6.019.096 | 607.376 | 1,59% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.409.393 | 545.852 | 1,42% | Hisse senetleri |
| Prescott Group Capital Management, L.L.C. | $5.369.684 | 541.845 | 1,41% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $5.349.973 | 539.856 | 1,41% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.109.677 | 414.700 | 1,08% | Alım opsiyonu |
| NORTHERN TRUST CORP | $4.014.948 | 405.141 | 1,06% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.910.555 | 394.607 | 1,03% | Hisse senetleri |
| EXCHANGE TRADED CONCEPTS, LLC | $3.555.540 | 358.783 | 0,94% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $3.480.392 | 351.200 | 0,92% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $3.326.886 | 335.710 | 0,88% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $3.097.598 | 312.573 | 0,82% | Hisse senetleri |
| Coastal Bridge Advisors, LLC | $2.743.256 | 276.817 | 0,72% | Hisse senetleri |
| Invesco Ltd. | $2.098.175 | 211.723 | 0,55% | Hisse senetleri |
| BALANCE CAPITAL PARTNERS L.P. | $1.972.179 | 199.009 | 0,52% | Hisse senetleri |
| ALGERT GLOBAL LLC | $1.784.395 | 180.060 | 0,47% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $1.746.449 | 176.231 | 0,46% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.689.463 | 170.481 | 0,44% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $1.637.935 | 165.281 | 0,43% | Hisse senetleri |
| PEAK6 LLC | $1.619.294 | 163.400 | 0,43% | Alım opsiyonu |
| CAXTON ASSOCIATES LLP | $1.532.552 | 154.647 | 0,40% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $1.499.938 | 151.356 | 0,39% | Hisse senetleri |
| Nuveen, LLC | $1.455.234 | 146.845 | 0,38% | Hisse senetleri |
| MORGAN STANLEY | $1.430.152 | 144.314 | 0,38% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1.387.400 | 140.000 | 0,37% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.368.548 | 134.040 | 0,36% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.297.565 | 130.935 | 0,34% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.297.219 | 130.900 | 0,34% | Satım opsiyonu |
| a16z Capital Management, L.L.C. | $1.075.909 | 108.568 | 0,28% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.073.253 | 108.300 | 0,28% | Alım opsiyonu |
| Numerai GP LLC | $1.036.606 | 104.602 | 0,27% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $974.718 | 98.357 | 0,26% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $964.467 | 72.900 | 0,25% | Alım opsiyonu |
| Ensign Peak Advisors, Inc | $931.332 | 93.979 | 0,25% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $803.592 | 81.089 | 0,21% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 Şubat 2025 | 9,50% | Değişiklik | · | SEC |
| Jason Kelly ×4 başvurular | 14 Şubat 2024 | · | İlk başvuru | · | SEC |
| Reshma Shetty, Bartholomew Canton ×4 başvurular | 14 Şubat 2024 | · | İlk başvuru | · | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 başvurular | 04 Mart 2022 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 17 içeriden öğrenenler · 5 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 Temmuz 2026 A | 316.483 | 0 | 2 | $-1.374.823 |
| Steven P. Coen | Chief Financial Officer | 21 Ağustos 2026 M | 51.851 | 0 | 10 | $-348.032 |
| Mark E. Dmytruk | Chief Financial Officer | 20 Mayıs 2025 M | 46.226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 Temmuz 2026 A | 436.422 | 0 | 3 | $-977.101 |
| Marie E. Fallon | Chief Accounting Officer | 01 Mayıs 2023 M | 183.010 | 0 | 0 | $0 |
| Christian O Henry | Yönetim kurulu üyesi | 15 Eylül 2026 S | 19.310 | 0 | 1 | $-35.400 |
| Sri Kosuri | Yönetim kurulu üyesi | 11 Haziran 2026 A | 24.067 | 0 | 0 | $0 |
| Ross Fubini | Yönetim kurulu üyesi | 11 Haziran 2026 A | 10.822 | 0 | 0 | $0 |
| Harry Sloan | Yönetim kurulu üyesi | 11 Haziran 2026 A | 271.418 | 0 | 0 | $0 |
| Shyam Sankar | Yönetim kurulu üyesi | 12 Haziran 2025 A | 72.372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Yönetim kurulu üyesi | 11 Haziran 2025 M | 15.003 | 0 | 0 | $0 |
| Myrtle S Potter | Yönetim kurulu üyesi | 11 Haziran 2025 M | 10.822 | 0 | 0 | $0 |
| Arie Belldegrun | Yönetim kurulu üyesi | 13 Haziran 2024 A | 194.925 | 0 | 0 | $0 |
| Reshma Kewalramani | Yönetim kurulu üyesi | 12 Haziran 2024 M | 186.002 | 0 | 0 | $0 |
| Marijn E Dekkers | Yönetim kurulu üyesi | 12 Haziran 2024 M | 386.480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Yönetim kurulu üyesi | 16 Eylül 2021 D | 31.590.948 | 0 | 0 | $0 |
| Barry Canton | 10% sahip | 28 Temmuz 2026 A | 436.422 | 0 | 3 | $-977.101 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 25 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,69% | 355.179 NS | 31 Temmuz 2026 | N-PORT |
| IDNA · iShares Trust | 0,31% | 115.910 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 167.123 SH | 01 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,08% | 160.915 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41.498 SH | 19 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,02% | 379.730 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 22.732 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.228.746 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549.889 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274.008 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 112.735 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 85.360 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.967 NS | 31 Temmuz 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 17.486 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4.528 NS | 31 Temmuz 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 324 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.838 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22.370 SH | 03 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 66.426 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 29.590 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 5.670 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.065 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.489.851 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.264 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 443.818 SH | 11 Eylül 2026 | Günlük |
DNA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
SAT
Medyan hedef
$7.00
-43,3%
0 0,0%
Güçlü Al
0 0,0%
Al
3 30,0%
Tut
5 50,0%
Sat
2 20,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
2 analist · 2026-10-03Ortalama hedef $7.00 -43,3%
Tüm hedeflerin üstünde →
Mevcut fiyat $12.35
Düşük$5.00
Ortalama$7.00
Yüksek$9.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
Son Haberler Bu şirketten bahseden son manşetler
Cathie Wood'un Şimdi Yığıldığı "Muhteşem Yedi" Hissesi
Nasdaq · 2 ay önce
Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
Yahoo Finance · 3 ay, 4 hafta önce
This Warren Buffett Stock Is Beating the S&P 500 in 2026
Nasdaq · 3 ay, 4 hafta önce
California Başkan Yargılayıcısı, 23andMe'ün sonucunu 2023 veri ihlali için mahkemeye götürür
BBC Business · 4 ay önce
DNA kendi kendine sürüntü kitleri yanıltıcı olduğu için yasaklandı
BBC Business · 4 ay, 1 hafta önce
Jim Cramer BillionToOne Hakkında: "Alın Diyorum"
Yahoo Finance · 4 ay, 2 hafta önce
Güneş yanığı enerji depolamanın yeni bir yoluna ilham verdi
BBC Business · 4 ay, 3 hafta önce
Esrar Satıcılarına Tüketicileri Riskler Konusunda Uyarmadıkları İddiasıyla Dava Açıldı
ZeroHedge · 4 ay, 3 hafta önce
1 Ayda %30 Yükseliş, Zcash Bitcoin'den Daha İyi Bir Alım mı?
Yahoo Finance · 5 ay, 1 hafta önce
SCHQ vs. TLT: Aynı Hazine DNA'sı, Çok Farklı Maliyet ve Süre
Nasdaq · 5 ay, 2 hafta önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026